Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study
Camidanlumab tesirine治疗复发或难治性经典霍奇金淋巴瘤:一项II期研究
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024015600
Herrera, Alex F; Ansell, Stephen M; Zinzani, Pier Luigi; Radford, John; Maddocks, Kami; Pinto, Antonio; Collins, Graham P; Bachanova, Veronika; Bartlett, Nancy L; Bence-Bruckler, Isabelle; Hamadani, Mehdi; Kline, Justin; Mayer, Jiří; Savage, Kerry J; Advani, Ranjana H; Caimi, Paolo F; Casasnovas, René-Olivier; Feldman, Tatyana; Hess, Brian; Bastos-Oreiro, Mariana; Iyengar, Sunil; Szomor, Árpád; Townsend, William; André, Marc; Dyczkowski, Jerzy; Havenith, Karin; Toukam, Marie; Pantano, Serafino; Cruz, Hans G; Wang, Luqiang; Negievich, Yanina; Lucero, Melanie; Wuerthner, Jens; Carlo-Stella, Carmelo